Deutsche Bank Downgrades Allscripts (MDRX) to Hold
- Top 10 News for 12/2: Crude Rips on OPEC Cut; Starbucks' Schultz Steps Down; Nonfarm Payrolls Flat in Nov.
- Unemployment Rate Drops to 4.6%
- Bond yields slip on U.S. jobs data, euro steady before Italy vote
- Alibaba (BABA) Founder Jack Ma Discuss Plans to Retire; 'I Don't Want to Die at the Office'
- Starbucks Coffee (SBUX) CEO Howard Schultz to Step Down, Appointed Executive Chairman; Kevin Johnson New CEO
News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.
Deutsche Bank downgraded Allscripts (NASDAQ: MDRX) from Buy to Hold with a price target of $11.00 (from $14.00). Analsyt George Hill thinks the Affordable Care Act might be repealed.
"We believe that there is a high likelihood that the Affordable Care Act gets repealed or significantly scaled back, creating uncertainty for provider organizations. As these organizations face a less certain revenue and capex future, we believe that spending on IT is likely to stall until provider organizations know what the next generation set of IT tools needed will look like. Given that outlook, we are downgrading CERN and MDRX shares to Hold given what we expect will be a less certain multi-year outlook for hospital based HCIT spend. While the Ryan plan does call for some investment in medical records, we believe many of these proposals were already covered by the HITECH Act and are unlikely to result in material incremental spending," said Hill.
Shares of Allscripts closed at $10.25 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Dougherty & Co Starts Allscripts (MDRX) at Neutral
- Deutsche Bank Upgrades American Axle (AXL) and Dana to (DAN) Buy
- Pivotal Research Downgrades Kroger (KR) to Hold
Create E-mail Alert Related CategoriesDowngrades
Related EntitiesDeutsche Bank
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!